In its ruling on EP 3 536 712 B1, the Düsseldorf Local Division of the UPC for the first time outlined crucial criteria for patent infringement based on second medical use cl...
Continue reading
Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfro...
Continue reading
We are delightet that IAM has recognized eight of our partners as Strategy 300 Global Leaders 2025:
Continue reading
For more awards and information, click here.
